Breast Cancer Stage
Item
diagnosis of stage i, ii, or iii breast cancer
boolean
C2216702 (UMLS CUI [1])
Metastatic breast cancer
Item
no metastatic breast cancer
boolean
C0278488 (UMLS CUI [1])
Inoperable or active loco-regional disease
Item
no inoperable or active loco-regional disease
boolean
C0006826 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C0277565 (UMLS CUI [2])
BMI
Item
body mass index (bmi) > 25
boolean
C1305855 (UMLS CUI [1])
Completed treatment for breast cancer
Item
patients must have completed treatment for breast cancer within the past 3-18 months
boolean
C0087111 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
hormone receptor status
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Menopausal status
Item
menopausal status not specified
boolean
C0455962 (UMLS CUI [1])
Willing to participate
Item
willing and able to attend supervised exercise sessions at least 3 times per week for a period of 24 weeks
boolean
C0021430 (UMLS CUI [1])
Transtheoretical model
Item
patients must be an exercise pre-contemplator, contemplator, or preparer as defined by the transtheoretical model
boolean
C3714361 (UMLS CUI [1])
Physical/psychiatric impairment
Item
no physical/psychiatric impairment that would seriously impair physical mobility
boolean
C0231171 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
Comorbidity
Item
no severe nausea, anorexia, or other diseases affecting health (e.g., arthritis and multiple sclerosis)
boolean
C0009488 (UMLS CUI [1])
Exercise
Item
more than 3 months since prior exercise and not currently engaged in exercise (two or more times per week for at least 30 minutes per session)
boolean
C0015259 (UMLS CUI [1])
Prior concurrent therapy
Item
prior concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
Disease characteristics
Item
see disease characteristics
boolean
C1705348 (UMLS CUI [1])
Endocrine treatments
Item
concurrent tamoxifen, other endocrine treatments, and trastuzumab (herceptin®) allowed
boolean
C0279025 (UMLS CUI [1])
Diet
Item
no concurrent alternative/complementary diets
boolean
C0012155 (UMLS CUI [1])
High-dose antioxidant supplement
Item
no concurrent high-dose antioxidant supplement therapy
boolean
C0003402 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
Hormone-replacement therapy or oral contraceptives
Item
more than 4 months since prior and no concurrent hormone-replacement therapy or oral contraceptives
boolean
C0282402 (UMLS CUI [1])
C0009905 (UMLS CUI [2])